A detailed history of Sterling Capital Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 1,789 shares of AKRO stock, worth $78,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,789
Previous 207 764.25%
Holding current value
$78,984
Previous $5.94 Million 738.02%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$26.75 - $35.28 $42,318 - $55,812
1,582 Added 764.25%
1,789 $49.8 Million
Q3 2024

Nov 12, 2024

BUY
$21.45 - $29.34 $4,440 - $6,073
207 New
207 $5.94 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.05B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.